secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEPHROS INC (NEPH)
CIK:        0001196298
Form:       8-K
Filed at:   2021-07-08T23:59:59+00:00
Accession:  0001493152-21-016427
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nephros reports preliminary Q2 2021 revenue $2.2M (+40% YoY); submits HDF product for FDA 510(k) clearance
--------------------------------------------------------------------------------

- Preliminary Q2 2021 net revenue ~$2.2M, >40% year-over-year increase.
- Six-month revenue >$5M, up 20% vs same periods in 2020 and 2019.
- Subsidiary SRP submitted HDF Assist Module for FDA 510(k) clearance; commercial launch planned at limited dialysis clinics.
- Pathogen Detection Systems segment generated >$50k in Q2 from on-site testing services.
- Consolidated cash at quarter end ~$8.3M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1196298/000149315221016427/0001493152-21-016427-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1196298/000149315221016427/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-21-016427

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer